Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
79 results about "Genus Bifidobacterium" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Composition containing aloe, probiotics and prebiotics and application of composition
InactiveCN104740138AIncrease the number ofThe effect of significantly modulating the intestinal flora of animalsOrganic active ingredientsMetabolism disorderBifidobacteriumIntestinal structure
The invention discloses a composition and an application thereof in regulating intestinal flora of animals. The composition contains aloe, probiotics and prebiotics, wherein the mass ratio of the aloe to the probiotics to the prebiotics is (6 to 3 to 1)-(6 to 1 to 3). The inventor discovers that the composition disclosed by the invention can effectively promote the proliferation of useful bacteria such as bifidobacterium and lactobacilli in animal intestines, so as to effectively regulate the intestinal flora of animals; therefore, the composition can be used for preventing or treating diabetes on the basis of the effect of the intestinal flora.
Owner:深圳华大基因农业控股有限公司 +1
Bifidobacterium breve CCFM1025, fermented food and application thereof
ActiveCN108949640ARelieve depression-like behaviorImprove the level ofNervous disorderBacteriaGut floraEnteropathy
The invention relates to bifidobacterium breve CCFM1025, a fermented food and application thereof. The bifidobacterium breve CCFM1025 can be used for improving the depression-like behavior of a depression mouse, improving 5-hydroxytryptamine in the brain of the depression mouse, improving the level of 5-hydroxytryptamine and a brain-derived neurotrophic factor, reducing the level of corticosteronein serum of the depression mouse, improving the level of 5-hydroxytryptamine in the serum of the depression mouse, improving intestinal flora disturbance of the depression mouse, reducing the abundance of intestinal veillonella, improving the abundance of bifidobacterium and mycoplasmataceae, improving alpha-diversity of intestinal flora and reducing occurrence of inflammatory bowel disease and obesity. By adopting the bifidobacterium breve CCFM1025, the mRNA level of tryptophan hydroxylase in a simulated entero-chromaffin cell can be improved, the secretion volume of 5-hydroxytryptophane ofthe cell can be improved, and a precursor substance is specifically provided to synthesis of 5-hydroxytryptamine in the brain. The bifidobacterium breve CCFM1025 has a wide application prospect.
Owner:无锡食生臻选生物科技有限公司
Bacterium of the genus bifidobacterium and fermented foods using the same
InactiveUS20050031735A1Maintain consistencyImprove survivabilityMilk preparationBacteriaAdditive ingredientBacterial counts
The present invention provides a bacterium belonging to the genus Bifidobacterium, which can exhibit a high viability in the storage under agitation and can produce a fermented food containing a large number of viable bacterial count. The present invention further provides a fermented food, which contains the bacterium belonging to the genus Bifidobacterium and exhibits various physiological effects such as inhibitory action against harmful intestinal bacteria and intestinal function controlling effects. The present invention further provides a bacterium belonging to the genus Bifidobacterium having a rate of viability of 30% or more, when the bacterium is stored in the aerobic condition under agitation at 10° C. for 14 days after culturing in a medium containing milk as a main ingredient until obtaining a viable count of 1×108 cfu / ml or more, and fermented food using the same.
Owner:YAKULT HONSHA KK
Sodium polyacrylate-grafted and sodium alginate-embedded probiotic microcapsule and preparation method thereof
InactiveCN104644612AHigh carboxyl contentImprove buffering effectDigestive systemUnknown materialsFood additiveBiology
The invention discloses a sodium polyacrylate-grafted and sodium alginate-embedded probiotic microcapsule, which is prepared by carrying out ionic crosslinking and embedding on probiotic with a complex of sodium polyacrylate-grafted sodium alginate and sodium alginate as an inner layer wall material, and coating chitosan on an outer layer. The embedded probiotic is one or more than two of lactobacillus, galactococcus or bifidobacterium; and the sodium polyacrylate is a state-approved food additive, and is safe and nontoxic in embedding. The buffer action on gastric acid caused by the inner layer wall material is increased through a grafting method; reduction of viable count in a gastric juice environment is reduced; meanwhile, the mechanical strength of the microcapsule is enhanced by cross-linking property of the capsule and calcium ions; the viscosity of a wall material solution is lower than that of an existing high polymer material; the preparation difficulty of the microcapsule is reduced; the prepared microcapsule has the functions of resisting gastric juice and accelerating intestinal release; the effective living bacteria count of intestinal tracts can be improved when the microcapsule is applied to embedding the probiotic; and the in-vivo probiotic function is enhanced.
Owner:TIANJIN UNIV OF SCI & TECH
Process for preparing fermented soybean milk
InactiveUS6599543B1Long storageEliminate contaminationEdible seed preservationLactobacillusFood flavorLactobacillus acidophilus
Disclosed is a process for preparing a fermented soybean milk comprising the steps of: inoculating a lactic acid bacterium of the genus Bifidobacterium, Lactobacillus bulgaricus and one strain selected from the group consisting of Lactobacillus acidophilus and Lactobacillus casei into soybean milk, and fermenting the same. According to the process of the present invention, lactic acid bacteria fermented soybean milk with great flavor can be provided.
Owner:FUJI OIL CO LTD
Use of a Bifidobacterium species lysate for treating sensitive skin
Cosmetic use of an effective amount of at least one lysate of at least one microorganism of the genus Bifidobacterium species and / or a fraction thereof, for preventing and / or treating a skin disorder in the case of sensitive skin.
Owner:LOREAL SA
Bifidobacterium adolescentis and use thereof
InactiveUS20190112674A1Improve their levelRelieve hyperglycemiaMilk preparationBacteriaBifidobacterium adolescentisDisease
Provided is a strain CCFM8630 of Bifidobacterium adolescentis and use thereof. The strain CCFM8630 of Bifidobacterium adolescentis can significantly increase neurotransmitter 5-hydroxytryptamine level in peripheral blood of rat, recover the hormone levels, for example testosterone and so on in peripheral blood of rat, normalize abnormal abundances of Bifidobacterium genus, Blautia genus and Turicibacter genus in intestinal flora of rat affected by high-fat high-starch diet, show pretty good tolerance to simulated gastrointestinal fluid and quickly colonize in intestinal, significantly improve pathological damages of tissues such as liver, duodenum and so on, and increase triglyceride and total cholesterol levels in serum and oral glucose tolerance of rat with metabolic syndrome caused by high-fat high-starch diet. The strain CCFM8630 of Bifidobacterium adolescentis can be used for preventing, relieving or treating metabolic disorder, such as metabolic syndrome, irritable bowel syndrome and mental diseases related to metabolic syndrome such as anxiety, depression and so on.
Owner:INFINITUS (CHINA) CO LTD
Bifidobacterium breve ccfm1025, its fermented food and its application
The present invention relates to bifidobacterium breve CCFM1025, its fermented food and application thereof. Bifidobacterium breve CCFM1025 of the present invention can improve the depression-like behavior of depressed mice, increase the levels of 5-hydroxytryptophan, 5-hydroxytryptophan and brain-derived neurotrophic factor in the brain of depressed mice, and reduce the levels of 5-hydroxytryptophan in the serum of depressed mice. Corticosterone levels, increased serum 5-hydroxytryptamine levels in depressed mice, improved intestinal flora disturbance in depressed mice, decreased intestinal Veillonellaceae abundance, increased the abundance of Bifidobacteria and Mycoplasmaceae , increase the α-diversity of intestinal flora, reduce the occurrence of inflammatory bowel disease and obesity; increase the mRNA level of tryptophan hydroxylase 1 in simulated enterochromaffin cells, and increase the level of 5-hydroxytryptophan in this cell Secretion, specifically providing precursors for the synthesis of 5-HT in the brain. It has broad application prospects.
Owner:无锡食生臻选生物科技有限公司
Bifidobacteria for reducing food, energy and/or fat intake
This invention relates to the use of a bacterium of the genus Bifidobacterium, particularly, but not exclusively, a bacterium of the Bifidobacterium animalis ssp. lactis strain 420 (B420) for use in reducing food, energy and / or fat intake.
Owner:DUPONT NUTRITION BIOSCIENCES APS
Method of producing fermented milk using novel lactic acid bacterium
ActiveCN101378662AHighly tuned gut effectsMilk preparationDigestive systemBiotechnologyGenus Lactococcus
A method of producing a fermented milk characterized by comprising conducting the fermentation with the use of, as lactic acid bacteria, a bacterium belonging to the genus Bifidobacterium and a bacterium belonging to the genus Lactococcus which has the following mycological properties: (1) such a fermentability that, in the case where the bacterium is cultured in a 10% reduced skim milk medium at a temperature of from 25 to 37 degrees centigrade for 16 hours, the medium is solidified; (2) such an effect of promoting the growth of Bifidobacterium longum that, in the case where the bacterium is cultured together with Bifidobacterium longum in the above-described medium and the pH value attains 4.4 to 4.6, the bifidobacterial count amounts to 5x10<8> CFU / g or more; and (3) such an effect of promoting the storage survival of Bifidobacterium longum that, in the case where the bacterium is cultured together with Bifidobacterium longum in the above-described medium, quenched at the point when the pH value attains 4.4 to 4.6 and then stored at 10 degrees centigrade for 2 weeks, the survival rate of Bifidobacterium longum amounts 30% or more; and a fermented milk produced by this production method.
Owner:MORINAGA MILK IND CO LTD
Bifidobacterium animalis and breeding method and application thereof
ActiveCN112175864AImprove Gut HealthImprove intestinal microenvironmentMilk preparationBacteriaBiotechnologyFeces
The invention relates to bifidobacterium animalis and a breeding method and application thereof, and belongs to the technical field of bifidobacterium lactis. According to the bifidobacterium animalisdisclosed by the invention, the strain is bifidobacterium animalis IU100 in the bifidobacterium genus, and the preservation number of the strain is CGMCC (China General Microbiological Culture Collection Center) No. 12942. The bifidobacterium animalis strain is a bifidobacterium strain obtained by continuously researching intestinal floras of the longevous in Bama district in Guangxi of China formany years, selecting elder excrement samples with a high intestinal bifidobacteria quantity and carrying out separation and purification by utilizing a selective culture method. The bifidobacteriumanimalis disclosed by the invention not only can improve intestinal health conditions of populations, but also has a potential effect of improving immunity; and meanwhile, the invention provides a simple and feasible breeding method and application. The breeding method is high in efficiency and low in cost.
Owner:SHANDONG DEYI DAIRY IND
Composition and method for the treatment of sinusitis
InactiveUS6767537B2Clean noseFlushing and cleansing of the sinus cavitiesBiocideBacteria material medical ingredientsMicrobiologyChronic sinusitis
Owner:NICOLAY PHIL ARNOLD
Bifidobacterium longum subsp. infantis ccfm687, its fermented food and its application
ActiveCN109055269BRelieve depression-like behaviorImprove the level ofNervous disorderBacteriaBiotechnologyNutrition
The invention relates to bifidobacterium longum subspecies CCFM687, fermented food and application thereof. Bifidobacterium longum infantile subspecies CCFM687 of the present invention can improve the depression-like behavior of depressed mice, improve the levels of 5-hydroxytryptamine, 5-hydroxytryptophan and brain-derived neurotrophic factor in the brain of depressed mice; improve depression Butyric acid content in the gut of mice; lower intestinal abundance of Desulfovibrio spp., increased abundance of Bifidobacterium and S24‑7 families, increased gut microbiota α‑diversity, and improved intestinal Intestinal flora disorder, reduce the occurrence of autism, inflammatory bowel disease, obesity and type I diabetes; increase the mRNA level of tryptophan hydroxylase 1 in simulated enterochromaffin cells, and increase the 5-hydroxychromatin level of the cells The secretion of amino acid provides precursor substances for the synthesis of 5-hydroxytryptamine in the brain. Therefore, it has broad application value.
Owner:JIANGNAN UNIV
Method for constructing novel bacterium belonging to the genus bifidobacterium
ActiveUS20120329059A1Improve survivabilityExhibit physiological effectMilk preparationSugar derivativesBacteroidesMicrobiology
A method for producing bacteria belonging to the genus Bifidobacterium having excellent viability even under various conditions with different environmental factors, novel bacteria belonging to the genus Bifidobacterium obtained by the method, and a method for detecting the bacteria are provided. By subculturing and storing bacteria belonging to the genus Bifidobacterium alternately in systems under conditions with different environmental factors, the bacteria belonging to the genus Bifidobacterium exhibiting excellent viability under all the conditions used for the alternate subculturing and storing can be produced.
Owner:YAKULT HONSHA KK
Healthy food for preventing and treating osteoporosis
InactiveCN111109607AEffective againstNo side effectsVitamin food ingredientsFood ingredient functionsLactobacillus rhamnosusProbiotic bacterium
The invention belongs to the field of healthy food, and particularly relates to healthy food for preventing and treating osteoporosis. According to the defects of an existing technology for preventingand treating osteoporosis, the healthy food is prepared from the following raw materials in parts by weight: 10-15 parts of bifidobacterium powder, 10-15 parts of lactobacillus powder, 10-15 parts ofstreptococcus thermophilus powder, 30-60 parts of saccharides, 15-20 parts of fruit powder, 1-3 parts of whey calcium (milk mineral salt) and 1-3 parts of vitamin D. Probiotic strains such as lactobacillus paracasei, lactobacillus plantarum, lactobacillus rhamnosus and bifidobacterium which have the effect on prevention and treatment of the osteoporosis are cultured and screened, and high-qualitycalcium raw materials beneficial to absorption and utilization of the human body are selected and supplemented. According to the healthy food for preventing and treating the osteoporosis, a dietary therapy method is adopted, through scientific and reasonable material matching, the healthy food is effectively used for people for preventing and treating the osteoporosis, no side effect exists, andthe healthy food has the health effect.
Owner:青岛康益生物科技有限公司
Polysaccharide produced by microorganism belonging to genus bifidobacterium
InactiveCN101218340AMoisturizingHave immune activationCosmetic preparationsOrganic active ingredientsMicroorganismCulture cell
Owner:MORISHITA JINTAN CO LTD +2
Composite microbial agent for degrading oil pollutants in oily sludge and preparation method and application thereof
PendingCN113862198ASolve processingSettlement feeBacteriaWater contaminantsMicrobial agentOil sludge
The invention discloses a composite microbial agent for degrading oil pollutants in oily sludge and a preparation method and application thereof. The composite microbial agent is prepared by mixing a Pseudomonas aeruginosa agent, a Bifidobacterium agent, a Bacillus subtilis agent and a Virgibacillus halodenitrificans agent according to a volume ratio of (1-4): (1-4) : (1-4) : (1-4). The invention also relates to application of the composite microbial agent for degrading oil pollutants in oily sludge in degrading petroleum substances. The composite microbial agent provided by the invention has a good degradation effect on petroleum hydrocarbon substances in the oily sludge, so that the oil substances in the oily sludge can be removed, the oil concentration in the oily sludge is reduced, and a great promotion effect is achieved on the oily sludge treatment work.
Owner:SHAANXI UNIV OF SCI & TECH
Lactobacillus paracasei and application thereof
PendingCN113355252AEffective regulationPromote positive micro-ecological balanceDough treatmentBacteriaBiotechnologyLactobacillus paracasei
The invention belongs to the field of biological health care, and particularly relates to lactobacillus paracasei and application thereof in regulating intestinal flora. The lactobacillus paracasei is lactobacillus paracasei (Lactobacillus paracasei) WG-7, and the preservation number of the lactobacillus paracasei WG-7 is CGMCC No.15961. Another purpose of the lactobacillus paracasei is to provide application of the lactobacillus paracasei WG-7 in regulating the intestinal flora, and particularly relates to application of the lactobacillus paracasei WG-7 in preparation of drugs and / or food and / or health care products for regulating the intestinal flora. The lactobacillus paracasei WG-7 can be used for effectively regulating the intestinal flora and promoting positive balance of micro-ecology of an organism, and can be used for effectively increasing the quantity of one or more of bifidobacteria and lactobacillus in intestinal tracts under the condition that the total quantity of the intestinal flora is basically not changed; and the quantity of one or more of escherichia coli and enterococcus in the intestinal tract is reduced.
Owner:南京卫岗乳业有限公司
Composition containing bacterium belonging to genus bifidobacterium as active ingredient
Owner:MORINAGA MILK IND CO LTD
Bifidobacterium bifidum capable of reducing colon pathological injury and relieving constipation
The invention discloses a bifidobacterium bifidum capable of reducing colon pathological injury and relieving constipation, and belongs to the field of microorganisms. The bifidobacterium bifidum CCFM1165 provided by the invention can effectively improve the first black stool time, the intestinal tract propulsion rate, the stool water content and the pathological damage of colon tissues of a constipation mouse. The strain provided by the invention can influence the content of excitement type and inhibition type gastrointestinal active peptides, and mainly increases the content of two short-chain fatty acids, so that the constipation symptom is relieved. Meanwhile, the bifidobacterium bifidum can effectively increase the abundance of bifidobacteria in excrement and can also relieve pathological damage of colon tissue, so that the effect of comprehensively relieving constipation diseases is achieved. In addition, compared with GDMCC NO.60939, the content of MTL in serum is better increased, secretion of 5-HT in colon tissue is promoted, and the propelling effect on small intestine peristalsis is more remarkable, so the GDMCC NO.60939 can be applied to disease control in a more targeted mode.
Owner:JIANGNAN UNIV
Bacterium of the genus bifidobacterium and fermented foods using the same
InactiveCN1589322AHigh physiological effectImprove survival rateMilk preparationBacteriaBacteroidesAdditive ingredient
The present invention provides a bacterium belonging to the genus Bifidobacterium, which can exhibit a high viability in the storage under agitation and can produce a fermented food containing a large number of viable bacterial count. The present invention further provides a fermented food, which contains the bacterium belonging to the genus Bifidobacterium and exhibits various physiological effects such as inhibitory action against harmful intestinal bacteria and intestinal function controlling effects. The present invention further provides a bacterium belonging to the genus Bifidobacteriumhaving a rate of viability of 30% or more, when the bacterium is stored in the aerobic condition under agitation at 10 DEG C for 14 days after culturing in a medium containing milk as a main ingredient until obtaining a viable count of 1 x 10<8> cfu / ml or more, and fermented food using the same.
Owner:YAKULT HONSHA KK
Composition for degrading opioid peptide
PendingCN111787933AMedication with peace of mindLess prone to side effectsNervous disorderBacteriaOpioid peptideMicrobiology
The present invention addresses the problem of providing an agent for degrading an opioid peptide or a composition for degrading an opioid peptide which requires no restriction on diet, shows no sideeffects even if used regularly and, therefore, can be continuously used free from anxiety. To solve this problem, provided are an agent for degrading an opioid peptide, a composition for degrading anopioid peptide, a medicinal composition for degrading an opioid peptide and a food or beverage composition for degrading an opioid peptide, each comprising, as an active ingredient, a bacterium belonging to the genus Bifidobacterium, a culture of the bacterium and / or treated cells of the bacterium.
Owner:MORINAGA MILK IND CO LTD
Composition, kit and method for detecting human intestinal bacteria
ActiveCN110699468AAccurate and efficient identificationNo non-specific amplificationMicrobiological testing/measurementMicroorganism based processesClostridium leptumBacteroides
The invention relates to the field of molecular biological detection, in particular to the field of human intestinal bacteria detection. The invention provides a composition for detecting seven intestinal bacteria, including Bifidobacterium (BIF), Streptococcus (STR), Bacteroides (BAC), Lactobacillus (LAC), Clostridium leptum (CLEP), Faecalibacterium (FAE) and Eubacterium rectale (ER), and also provides application of the composition in detecting human intestinal bacteria, a kit comprising the composition and a method for detecting human intestinal bacteria.
Owner:北京圣维尔医学检验实验室有限公司
Bifidobacteria for increasing lean body mass
PendingCN109069553AIncrease lean body massOrganic active ingredientsBacteriaBiotechnologyMicrobiology
This invention relates to the use of a composition comprising a bacterium of the genus Bifidobacterium, particularly, but not exclusively, a bacterium of the Bifidobacterium animalis ssp. lactis (strain) 420 (B420), and one or more prebiotics and / or fibres, for use in increasing lean body mass in a mammal.
Owner:DUPONT NUTRITION BIOSCIENCES APS
Antibiotic-sensitive lactic acid bacteria strains
Many probiotic Bifidobacteriacea contains an active tetW that renders the cells resistant to tetracycline. This may present a risk of a horizontal transfer of functional antibiotic genes. The present invention relates to a method of obtaining novel tetracycline-sensitive strains of the genus of Bifidobacteriacea (Bifidobacterium sp.). In particular, the present invention relates to novel antibiotic-sensitive strains obtained from antibiotic-resistant probiotic strains and the use of such novel strains for the preparation of a food or feed product or a dosage form comprising viable organisms.
Owner:CHR HANSEN AS
Probiotic bacterial strains and symbiotic composition containing the same intended for infant food
The invention relates to probiotic bacterial strains and symbiotic composition containing the same intended for infant food. The present invention relates to a selection of probiotic strains belongingto the genus Bifidobacterium and to a symbiotic composition containing the same, intended for feeding infants.
Owner:PROBIOTICAL
Bacterial strains belonging to the genus bifidobacterium for use in the treatment of hypercholesterolaemia
InactiveCN103648512AMetabolism disorderBacteria material medical ingredientsBacteroidesAloe arborescens
The present invention relates to selected bacterial strains belonging to the genus Bifidobacterium for use in the treatment of hypercholesterolaemia. In particular, the present invention relates to a food composition or supplement product or medical device or pharmaceutical composition comprising said bacterial strains in association with sterols or phytosterols and / or stanols or phytostanols and / or glucomannan and / or konjac gum and / or prebiotic fibres and / or fermented red rice and / or betaglucans from oats, oat bran, barley, barley bran and / or aloe arborescens gel in lyophilized form.
Owner:PROBIOTICAL
Red pitaya enzyme, preparation method and application thereof
A red dragon fruit enzyme, preparation method and application thereof relate to the field of health food with health care effects. The red pitaya enzyme in the embodiment of the present invention is mainly prepared from the red pitaya fermentation liquid rich in short-chain fatty acids and functional galacto-oligosaccharides. The microbial combination starter of Fidobacterium, Bacteroides, and Eubacterium is obtained by fermentation and filtration by a three-step directional fermentation method. The pitaya enzyme is easily absorbed by the human body, has comprehensive effects, and has high economic value. The pitaya enzyme of the embodiment of the present invention can be used to regulate the gene expression of gastrointestinal mucosal cells, repair gastrointestinal mucosa, and assist in the treatment of gastric ulcer; it can be used to regulate the intestinal flora environment, relieve bowel movements, and prevent colorectal cancer; Improve the basic metabolism of the human body and have a good hypoglycemic effect.
Owner:上海合庆火龙果科技开发有限公司 +2
Novel shuttle vector
Owner:AZUSAPHARMA SCI INC
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com